Inventor · disambiguated record
Kristin Strumane
Also filed as: STRUMANE KRISTIN
5 granted patents·15 pending applications·5 citations·filing 2004–2024
69Inventor score
Top patents by PatentIndex Score
20 records- 0190US10882913B2Anti-DR5 antibodies and methods of use thereofGENMAB BV·Filed 2019·Granted Jan 5, 2021·4 cites·23 claims
- 0280US2025066506A1Bispecific antibodies against her2GENMAB AS·Filed 2024·Application pending·0 cites
- 0376US2022411522A1Anti-death receptor antibodies and methods of use thereofGENMAB BV·Filed 2022·Application pending·0 cites
- 0475US12173076B2Polypeptide variants and uses thereofGENMAB BV·Filed 2018·Granted Dec 24, 2024·1 cites·15 claims
- 0573US12247080B2Anti-DR5 antibodies and methods of use thereofGENMAB BV·Filed 2020·Granted Mar 11, 2025·0 cites·15 claims
- 0673US2025326854A1Polypeptide variants and uses thereofGENMAB BV·Filed 2024·Application pending·0 cites
- 0767US2021324105A1Bispecific antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 0866US2023107363A1Polypeptide variants and uses thereofGENMAB BV·Filed 2022·Application pending·0 cites
- 0964US2022332801A1Antibodies and methods of use thereof in treatment of infectious diseaseGENMAB BV·Filed 2021·Application pending·0 cites
- 1061US2019202926A1Anti-death receptor antibodies and methods of use thereofGENMAB BV·Filed 2016·Application pending·0 cites
- 1161US2019144554A1Anti-dr5 antibodies and methods of use thereofGENMAB BV·Filed 2016·Application pending·0 cites
- 1253US2023293680A1A composition of anti-dr5 antibodies and an immunomodulatory imide drug for use in treating multiple myelomaGENMAB BV·Filed 2021·Application pending·0 cites
- 1353US2017369590A1Bispecific antibodies against her2GENMAB AS·Filed 2017·Application pending·0 cites
- 1450US2020123237A1Antibodies and methods of use thereof in treatment of infectious diseaseGENMAB BV·Filed 2017·Application pending·0 cites
- 1549US12338289B2Antibody variant combinations and uses thereofGENMAB BV·Filed 2019·Granted Jun 24, 2025·0 cites·17 claims
- 1647US2019276549A1Polypeptide variants and uses thereofGENMAB BV·Filed 2017·Application pending·0 cites
- 1744US7569668B2Method to control tumor progression and invasivenessVLAAMS INTERUNIV INST BIOTECH·Filed 2006·Granted Aug 4, 2009·0 cites·1 claims
- 1844US2021107988A1Polypeptide variants and uses thereofGENMAB BV·Filed 2019·Application pending·0 cites
- 1941US2014170148A1Bispecific antibodies against her2DE GOEIJ BART·Filed 2012·Application pending·0 cites
- 2033US2005089896A1Method to control tumor progression and invasivenessFiled 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →